Open AccessThe effect of dipeptidyl peptidase-IV inhibitor sitagliptin on the immune functions in patients with type 2 diabetes
Author(s) -
Sromova Lucie,
Petr Bušek,
Helena Marečková,
M Andĕl,
Aleksi Šedo
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.00154
Subject(s) - sitagliptin , dipeptidyl peptidase , vildagliptin , immune system , medicine , sitagliptin phosphate , diabetes mellitus , type 2 diabetes mellitus , dipeptidyl peptidase 4 , endocrinology , pharmacology , type 2 diabetes , immunology , chemistry , biochemistry , enzyme